Search
Now showing items 1-8 of 8
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
| Date Issued:
2020 | Copyright:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access
Preprint
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
| Date Issued:
2021 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres
| Date Issued:
2021 | Copyright:
open access
Preprint
Combination of antiviral drugs to inhibit SARS-CoV-2 polymerase and exonuclease as potential COVID-19 therapeutics
| Date Issued:
2021 | Copyright:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Preprint
The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control
| Date Issued:
2020 | Copyright:
open access